Study on the pathogenesis of drug-induced gingival overgrowth -A study with deficient mice
药物性牙龈增生发病机制的研究——缺陷小鼠研究
基本信息
- 批准号:13470463
- 负责人:
- 金额:$ 8.58万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:2001
- 资助国家:日本
- 起止时间:2001 至 2003
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Drug-induced gingival overgrowth develops as a side effect of certain medications. We previously reported that phenytoin and cyclosporine, well known drugs causing gingival overgrowth, suppressed cathepsin-L mRNA expression as well as its activity in gingival fibroblasts. Therefore, we first investigated the effects of nifedipine, another drug causing the disease, on lysosomal enzyme activity. As a result, nifedipine also suppressed cathepsin-L mRNA expression and its activity. Thus, all three drugs causing gingival overgrowth turned out to suppress cathepsin-L activity in vitro. Based on this observation, we investigated the in vivo effects of "complete loss of function" of cathepsin-L by using cathepsin-L deficient mice. Cathepsin-L deficient mice developed gingival overgrowth, while wild type mice did not. flistologically, overgrown gingival was characterized by a thickened epithelium as well as thickened connective tissue with elongated rete pegs into the connective tissue, phenotype extremely similar to that observed in human gingival overgrowth.On the other hand, it is well known that cyclosporine exhibit anti-angiogenic effect, and that very few newly synthesized capillaries are observed in the lesion of drug-induced gingival overgrowth. We found that this was accompanied by the reduced expression of vascular endothelial growth factor via suppression of c jun N-terminal kinase activity by cyclosporine.Finally, it is essential to keep particular blood drug concentration to develop gingival overgrowth. It has been reported that there exist several single nucleotide polymorphisms in the coding region of the enzyme responsible for metabolizing these drugs We found that particular genotype is closely associated with poor metabolic ability, and thus, we concluded that examining the genotype may be quite useful in predicting the disease susceptibility.
药物引起的牙龈过度生长是某些药物的副作用。我们以前曾报道,苯妥英钠和环孢素,众所周知的药物引起牙龈增生,抑制组织蛋白酶-L mRNA的表达,以及其在牙龈成纤维细胞的活性。因此,我们首先研究了另一种引起这种疾病的药物硝苯地平对溶酶体酶活性的影响。结果,硝苯地平还抑制组织蛋白酶-L mRNA的表达及其活性。因此,所有这三种药物引起牙龈增生原来抑制组织蛋白酶-L的活性在体外。基于这一观察结果,我们研究了组织蛋白酶-L的“功能完全丧失”的体内影响,通过使用组织蛋白酶-L缺陷小鼠。组织蛋白酶-L缺陷小鼠牙龈过度生长,而野生型小鼠没有。从组织学上看,牙龈增生的特征是上皮细胞和结缔组织增厚,结缔组织中有延长的网钉,表型与人类牙龈增生极为相似,另一方面,众所周知,环孢素具有抗血管生成作用,在药物诱导的牙龈增生病变中观察到很少新合成的毛细血管。我们发现,这是伴随着减少血管内皮生长因子的表达,通过抑制c-jun N-末端激酶的活性环孢素。最后,它是必要的,以保持特定的血药浓度牙龈过度生长。据报道,在负责代谢这些药物的酶的编码区存在几个单核苷酸多态性,我们发现特定的基因型与代谢能力差密切相关,因此,我们认为检测基因型可能是预测疾病易感性的一个很有用的方法。
项目成果
期刊论文数量(24)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
山田比左, 西村英紀 他: "カルシウム拮抗剤ニフェジピンは歯肉線維芽細胞のカテプシンL活性を抑制する"日歯保存誌. 44(春期特別号). 96 (2001)
Hisa Yamada、Hideki Nishimura 等人:“钙拮抗剂硝苯地平抑制牙龈成纤维细胞中的组织蛋白酶 L 活性”,Journal of Japanese Dental Preservation 44(春季特刊)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Naruishi K, Nishimura F, Yamada-Naruishi H, Omori K, Yamaguchi M, Takashiba S.: "C jun N-terminal kinase (JNK) inhibitor, SP600125, blocks interleukin (IL)-6-induced vascular endothelial growth factor (VEGF) production : cyclosporine A partially, mimics t
Naruishi K、Nishimura F、Yamada-Naruishi H、Omori K、Yamaguchi M、Takashiba S.:“C jun N 末端激酶 (JNK) 抑制剂 SP600125 可阻断白细胞介素 (IL)-6 诱导的血管内皮生长因子 (VEGF)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Soga Y, et al.: "CYP2C polymorphisms, phenytoin metabolism and gingival overgrowth in epileptic subjects"Life Sciences. 74(7). 827-834 (2004)
Soga Y 等人:“癫痫患者的 CYP2C 多态性、苯妥英代谢和牙龈过度生长”《生命科学》。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Nishimura F., et al.: "Cathepsin-L, a key molecule in the pathogenesis of drug-induced and I-cell disease-mediated gingival overgrowth: a study with cathepsin-L-deficient mice."American Journal of Pathology. 161. 2047-2052 (2002)
Nishimura F. 等人:“组织蛋白酶-L,药物诱导和 I 细胞疾病介导的牙龈过度生长的发病机制中的关键分子:对组织蛋白酶-L 缺陷小鼠的研究。”美国病理学杂志。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Naruishi K., et al.: "C-jun N-terminal kinase (JNK) inhibitor, SP600125,blocks interleukin (IL)-6-induced vascular endothelial growth factor (VEGF) production : cyclosporine A partially mimics this inhibitory effect."Transplantation. 76. 1380-1382 (2003)
Naruishi K. 等人:“C-jun N 末端激酶 (JNK) 抑制剂 SP600125 可阻断白细胞介素 (IL)-6 诱导的血管内皮生长因子 (VEGF) 产生:环孢菌素 A 部分模仿这种抑制作用。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
NISHIMURA Fusanori其他文献
NISHIMURA Fusanori的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('NISHIMURA Fusanori', 18)}}的其他基金
Comprehensive analysis of the molecules up- or down- regulataed in dental pulp cells co-cultured with macrophages
巨噬细胞共培养牙髓细胞上调或下调分子的综合分析
- 批准号:
23659889 - 财政年份:2011
- 资助金额:
$ 8.58万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Basic study to unify periodontal medicine and anti-aging medicine
牙周医学与抗衰老医学统一的基础研究
- 批准号:
21390556 - 财政年份:2009
- 资助金额:
$ 8.58万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Study on the pathogenesis of periodontal disease in patients with Down's syndrome
唐氏综合症患者牙周病发病机制的研究
- 批准号:
10671966 - 财政年份:1998
- 资助金额:
$ 8.58万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
Single turnover covalent chaperones for disease related lysosomal enzymes
疾病相关溶酶体酶的单周转共价伴侣
- 批准号:
421413 - 财政年份:2020
- 资助金额:
$ 8.58万 - 项目类别:
Operating Grants
Mechanisms Of Er-To-Golgi Transport Of Lysosomal Enzymes
溶酶体酶从 Er 到高尔基体的转运机制
- 批准号:
10345430 - 财政年份:2019
- 资助金额:
$ 8.58万 - 项目类别:
Mechanisms Of Er-To-Golgi Transport Of Lysosomal Enzymes
溶酶体酶从 Er 到高尔基体的转运机制
- 批准号:
10376728 - 财政年份:2019
- 资助金额:
$ 8.58万 - 项目类别:
The role of lysosomes and subcellular distribution of lysosomal enzymes in early acute pancreatitis
溶酶体和溶酶体酶的亚细胞分布在早期急性胰腺炎中的作用
- 批准号:
427709435 - 财政年份:2019
- 资助金额:
$ 8.58万 - 项目类别:
Research Grants
Mechanisms Of Er-To-Golgi Transport Of Lysosomal Enzymes
溶酶体酶从 Er 到高尔基体的转运机制
- 批准号:
10094001 - 财政年份:2019
- 资助金额:
$ 8.58万 - 项目类别:
Lysosomal Enzymes in Outflow Pathway Physiology and Pathophysiology
流出途径生理学和病理生理学中的溶酶体酶
- 批准号:
9284304 - 财政年份:2017
- 资助金额:
$ 8.58万 - 项目类别:
Role of lysosomal enzymes cathepsins B and D in neuronal vulnerability: potential implications in Alzheimer's disease pathology
溶酶体酶组织蛋白酶 B 和 D 在神经元脆弱性中的作用:对阿尔茨海默病病理学的潜在影响
- 批准号:
369603 - 财政年份:2017
- 资助金额:
$ 8.58万 - 项目类别:
Operating Grants
Effect of lysosomal enzymes on alpha-synuclein accumulation causing neurodegeneration
溶酶体酶对引起神经变性的α-突触核蛋白积累的影响
- 批准号:
15K06764 - 财政年份:2015
- 资助金额:
$ 8.58万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Lysosomal Enzymes and Associated Human Genetic Diseases
溶酶体酶和相关人类遗传疾病
- 批准号:
8709755 - 财政年份:2013
- 资助金额:
$ 8.58万 - 项目类别:
in vivo imaging of transcytosis of lysosomal enzymes
溶酶体酶转胞吞作用的体内成像
- 批准号:
24590249 - 财政年份:2012
- 资助金额:
$ 8.58万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




